The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Banned: Key Facts on the Latest FDA Decision Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review